Lundbeck Reports 16% Revenue Growth in H1 2026
Lundbeck's total revenue grew by 16% in the first half of 2026, driven by strong performance from Vyepti and Rexulti. The US and Europe markets showed double-digit growth.
Copenhagen – Lundbeck announced total revenue of DKK 13,588 million for the first six months of 2026, a 16% increase in constant exchange rates (CER). The company attributed the growth to continued strong commercial momentum, particularly from its Vyepti and Rexulti products, with both the US and Europe markets delivering double-digit growth.
The company's transition to a partnership model in 27 markets is progressing as planned and shaped the results. This strategic shift is part of Lundbeck's ongoing commercial execution.
Adjusting for a planned one-time inventory build of DKK 470 million in these markets during the first quarter of 2026, the underlying revenue growth was 13% CER. This indicates sustained performance despite the inventory adjustment.
Lundbeck reiterated its focus on executing its commercial strategy to achieve its business objectives for the year.